Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Quarterly earnings expected at $1.24 per share, up 8.8% year-over-year. Forecasted revenue of $438.15 million, marking a 9.5% increase year-over-year. No revisions in consensus EPS estimates signal stability in analysts' forecasts. Negative projections for 'Sales- Non-Medical' down by 22.1% from last year. Analysts predict mixed performance in medical sales across various segments.
- Quarterly earnings expected at $1.24 per share, up 8.8% year-over-year.
- Forecasted revenue of $438.15 million, marking a 9.5% increase year-over-year.
- No revisions in consensus EPS estimates signal stability in analysts' forecasts.
- Negative projections for 'Sales- Non-Medical' down by 22.1% from last year.
- Analysts predict mixed performance in medical sales across various segments.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.